[Multidisciplinary position paper on the management of patent foramen ovale in the presence of cryptogenic cerebral ischemia - Italian version 2013].
暂无分享,去创建一个
G. Anzola | G. Guagliumi | G. Palareti | A. Gaspardone | D. Toni | G. Rigatelli | E. Onorato | C. Pristipino | M. Chessa | G. Santoro | F. Bedogni | G. Ussia | A. Bartorelli | A. Cremonesi | A. Donti | R. Violini | M. Cecconi | S. Rakar | L. Ballerini | G. Neri
[1] I. Palacios,et al. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials. , 2013, European heart journal.
[2] G. Anzola,et al. PEDIATRIC AND CONGENITAL HEART DISEASE Original Studies Management of Patients with Patent Foramen Ovale and Cryptogenic Stroke: A Collaborative, Multidisciplinary, Position Paper , 2013 .
[3] D. Kent,et al. Still no closure on the question of PFO closure. , 2013, The New England journal of medicine.
[4] J. Carroll,et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. , 2013, The New England journal of medicine.
[5] G. Schuler,et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. , 2013, The New England journal of medicine.
[6] R. Felberg,et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. , 2012, The New England journal of medicine.
[7] W. Ghali,et al. Recurrent cerebral ischemia in medically treated patent foramen ovale: A meta-analysis , 2011, Neurology.
[8] S. Cook,et al. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[9] M. Tatagiba,et al. Genetics of Moyamoya disease , 2010, Journal of Human Genetics.
[10] G. Anzola,et al. Patent foramen ovale (PFO) and cryptogenic stroke , 2010, Journal of thrombosis and haemostasis : JTH.
[11] P. Colonna,et al. Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC). , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[12] G. Rigatelli,et al. Patent oval foramen transcatheter closure: results of a strategy based on tailoring the device to the specific patient’s anatomy , 2010, Cardiology in the Young.
[13] P. Gorelick,et al. Inherited metabolic disorders and stroke part 2: homocystinuria, organic acidurias, and urea cycle disorders. , 2010, Archives of neurology.
[14] D. Kozel,et al. Transthoracic second harmonic two- and three-dimensional echocardiography for detection of patent foramen ovale. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[15] F. Viader,et al. Silent Cerebral Infarcts in Patients With Pulmonary Embolism and a Patent Foramen Ovale: A Prospective Diffusion-Weighted MRI Study , 2009, Stroke.
[16] B. Hemmer,et al. Lesion patterns in patients with cryptogenic stroke with and without right‐to‐left‐shunt , 2009, European journal of neurology.
[17] A. Gaspardone,et al. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage. , 2009, The American journal of cardiology.
[18] K. Whitehead,et al. Unusual Presentation of Nickel Allergy Requiring Explantation of an Amplatzer Atrial Septal Occluder Device , 2009, Clinical cardiology.
[19] D. Kent,et al. Patent Foramen Ovale in Cryptogenic Stroke: Incidental or Pathogenic? , 2009, Stroke.
[20] R. Sacco,et al. Patent Foramen Ovale, Cardiac Valve Thickening, and Antiphospholipid Antibodies as Risk Factors for Subsequent Vascular Events: The PICSS-APASS Study , 2009, Stroke.
[21] V. Pasceri,et al. Transcathether occlusion of interatrial communications: postprocedural transoesophageal echocardiography allows timely detection and treatment of intracardiac thrombus formation. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[22] A. Grau,et al. Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale? , 2009, Thrombosis and Haemostasis.
[23] I. Palacios,et al. Echocardiographic Assessment of Percutaneous Patent Foramen Ovale and Atrial Septal Defect Closure Complications , 2009, Circulation. Cardiovascular imaging.
[24] J. Finsterer,et al. Detection of paroxysmal atrial fibrillation and patent foramen ovale in cryptogenic stroke , 2009, European journal of neurology.
[25] E. Tuzcu,et al. Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. , 2009, The American journal of cardiology.
[26] K. Chun. Patent Foramen Ovale and Cryptogenic Stroke , 2008 .
[27] J. Martí-Fàbregas,et al. Recurrent Stroke and Massive Right-to-Left Shunt: Results From the Prospective Spanish Multicenter (CODICIA) Study , 2008, Stroke.
[28] R. Schräder,et al. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults. , 2008, The American journal of cardiology.
[29] M. Schwerzmann,et al. Atrial Fibrillation following Device Closure of Patent Foramen Ovale , 2008, Cardiology.
[30] S. Windecker,et al. Safety and feasibility of percutaneous closure of patent foramen ovale without intra-procedural echocardiography in 825 patients. , 2007, Swiss medical weekly.
[31] Eso Writing,et al. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008 , 2008 .
[32] M. Olschewski,et al. Patent foramen ovale and cryptogenic stroke in older patients. , 2007, The New England journal of medicine.
[33] N. Namboodiri,et al. The 'aortic rim' recount: embolization of interatrial septal occluder into the main pulmonary artery bifurcation after atrial septal defect closure. , 2007, Interactive cardiovascular and thoracic surgery.
[34] J. Tobis,et al. Five-year experience with percutaneous closure of patent foramen ovale. , 2007, The American journal of cardiology.
[35] A. Algra,et al. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial , 2007, The Lancet Neurology.
[36] S Claiborne Johnston,et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack , 2007, The Lancet.
[37] F. Gimigliano,et al. Patent foramen ovale and cryptogenic stroke. A critical review , 2007, Journal of cardiovascular medicine.
[38] M. Cheitlin. Patent Foramen Ovale: Innocent or Guilty? Evidence From a Prospective Population-Based Study , 2007 .
[39] P. McLaughlin,et al. Transcatheter closure of aortic sinus to left atrial fistula caused by erosion of amplatzer septal occluder , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[40] M. Kaps,et al. Embolic Lesion Pattern in Stroke Patients With Patent Foramen Ovale Compared With Patients Lacking an Embolic Source , 2006, Stroke.
[41] Fuad M. Kiblawi,et al. Transcatheter closure of patent foramen ovale in older adults , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[42] G. Anzola,et al. Brain death worldwide: Accepted fact but no global consensus in diagnostic criteria , 2006, Neurology.
[43] S. Kasner,et al. PFO management: Neurologists vs cardiologists , 2005, Neurology.
[44] M. Kaps,et al. Identification of Embolic Stroke Patterns by Diffusion-Weighted MRI in Clinically Defined Lacunar Stroke Syndromes , 2005, Stroke.
[45] S. Windecker,et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. , 2018, Neurology.
[46] J. Cheatham,et al. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[47] R. Schräder. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices. , 2004, Journal of the American College of Cardiology.
[48] P. Block,et al. Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: Acute results from the FORECAST registry , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[49] A. Kelion,et al. Transthoracic echocardiography using second harmonic imaging with Valsalva manoeuvre for the detection of right to left shunts. , 2004, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[50] M. Zennaro,et al. Transcatheter atrial septal defect closure assisted by intracardiac echocardiography: 3-year follow-up. , 2004, Journal of interventional cardiology.
[51] R. Sacco,et al. Classification of Ischemic Stroke , 2004 .
[52] E. Foster,et al. Harmonic Imaging Improves Sensitivity at the Expense of Specificity in the Detection of Patent Foramen Ovale , 2004, Echocardiography.
[53] Paul Khairy,et al. Transcatheter Closure versus Medical Therapy of Patent Foramen Ovale and Presumed Paradoxical Thromboemboli , 2003, Annals of Internal Medicine.
[54] G. Anzola,et al. Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale , 2003, European journal of neurology.
[55] J. Mas. Patent Foramen Ovale and Stroke , 2003, Practical Neurology.
[56] G. Anzola,et al. Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients. , 2003, Journal of interventional cardiology.
[57] S. Ho,et al. Morphological features pertinent to interventional closure of patent oval foramen. , 2003, Journal of interventional cardiology.
[58] D. Darby,et al. Examining the Lacunar Hypothesis With Diffusion and Perfusion Magnetic Resonance Imaging , 2002, Stroke.
[59] R. Sacco,et al. Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale: Patent Foramen Ovale in Cryptogenic Stroke Study , 2002, Circulation.
[60] R. Sacco,et al. Antithrombotic and thrombolytic therapy for ischemic stroke. , 2001, Chest.
[61] J. Coste,et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. , 2001, The New England journal of medicine.
[62] K. Furie,et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. , 2001, The New England journal of medicine.
[63] H. Schuchlenz,et al. Catheter closure of the persistent foramen ovale: mid-term results in 162 patients. , 2001, Journal of interventional cardiology.
[64] I. Bone,et al. Interatrial septal abnormalities and stroke , 2000, Neurology.
[65] Z. Yiğit,et al. Atrial Septal Aneurysm in Adult Patients , 1999 .
[66] D. Tanné,et al. Anticardiolipin antibodies and their associations with cerebrovascular risk factors , 1999, Neurology.
[67] P. Penther. [Patent foramen ovale: an anatomical study. Apropos of 500 consecutive autopsies]. , 1994, Archives des maladies du coeur et des vaisseaux.
[68] David Lee Gordon,et al. Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.
[69] J. Newburger,et al. Transcatheter Closure of Patent Foramen Ovale After Presumed Paradoxical Embolism , 1992, Circulation.
[70] Daniel B Hier,et al. Infarcts of undetermined cause: The NINCDS stroke data bank , 1989, Annals of neurology.
[71] H. J. Smith,et al. PATENT FORAMEN OVALE IN YOUNG STROKE PATIENTS , 1988, The Lancet.